Detalhe da pesquisa
1.
Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial.
Lancet Oncol;
23(3): e105-e115, 2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35240087
2.
Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial.
Lancet Oncol;
22(8): 1093-1102, 2021 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34237249
3.
Personalized designs of adjuvant radiotherapy for pancreatic cancer based on molecular profiles.
Cancer Sci;
112(1): 287-295, 2021 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32418280
4.
Effect of stereotactic body radiotherapy dose escalation plus pembrolizumab and trametinib versus stereotactic body radiotherapy dose escalation plus gemcitabine for locally recurrent pancreatic cancer after surgical resection on survival outcomes: A secondary analysis of an open-label, randomised, controlled, phase 2 trial.
EClinicalMedicine;
55: 101764, 2023 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36471691
5.
Short-Term Outcomes and Clinical Efficacy of Stereotactic Body Radiation Therapy (SBRT) for Oligometastases of Prostate Cancer in China.
Front Oncol;
12: 879310, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35574331
6.
Stereotactic body radiation therapy with sequential S-1 for patients with locally advanced pancreatic cancer and poor performance status: An open-label, single-arm, phase 2 trial.
Radiother Oncol;
162: 178-184, 2021 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34274393
7.
Development and Validation of Multicenter Predictive Nomograms for Locally Advanced Pancreatic Cancer After Chemoradiotherapy.
Front Oncol;
11: 688576, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34169000
8.
Re-Irradiation With Stereotactic Body Radiotherapy for In-Field Recurrence of Pancreatic Cancer After Prior Stereotactic Body Radiotherapy: Analysis of 24 Consecutive Cases.
Front Oncol;
11: 729490, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34796108
9.
Five-year outcomes of stereotactic body radiation therapy (SBRT) for prostate cancer: the largest experience in China.
J Cancer Res Clin Oncol;
147(12): 3557-3564, 2021 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34528135
10.
Clinical efficacy of Stereotactic Body Radiation Therapy (SBRT) for adrenal gland metastases: A multi-center retrospective study from China.
Sci Rep;
10(1): 7836, 2020 05 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32398700
11.
Failure patterns and outcomes of dose escalation of stereotactic body radiotherapy for locally advanced pancreatic cancer: a multicenter cohort study.
Ther Adv Med Oncol;
12: 1758835920977155, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33403017
12.
Validation of the eighth edition of the AJCC staging system for patients with pancreatic adenocarcinoma initially receiving chemoradiotherapy and proposal of modifications.
Cancer Biol Med;
17(2): 492-500, 2020 05 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32587784
13.
Stereotactic Radiation Therapy (SRT) for Brain Metastases of Multiple Primary Tumors: A Single Institution Retrospective Analysis.
Front Oncol;
9: 1352, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31921625
14.
Patterns of Local Failure After Stereotactic Body Radiation Therapy and Sequential Chemotherapy as Initial Treatment for Pancreatic Cancer: Implications of Target Volume Design.
Int J Radiat Oncol Biol Phys;
104(1): 101-110, 2019 05 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30684663
15.
Short-term outcomes and clinical efficacy of stereotactic body radiation therapy (SBRT) in treatment of adrenal gland metastases from lung cancer.
Radiat Oncol;
13(1): 205, 2018 Oct 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30348187
16.
Optimization of dose distributions of target volumes and organs at risk during stereotactic body radiation therapy for pancreatic cancer with dose-limiting auto-shells.
Radiat Oncol;
13(1): 11, 2018 Jan 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29357875
17.
Prediction of overall survival after re-irradiation with stereotactic body radiation therapy for pancreatic cancer with a novel prognostic model (the SCAD score).
Radiother Oncol;
129(2): 313-318, 2018 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30217337
18.
Health-related quality of life for gemcitabine and nab-paclitaxel plus radiotherapy versus gemcitabine and S-1 plus radiotherapy in patients with metastatic pancreatic cancer.
Cancer Manag Res;
10: 4805-4815, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30425574
19.
A modified formula for dose calculations of stereotactic ablative body radiotherapy for non-small cell lung cancer.
Med Dosim;
43(3): 207-213, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28993019
20.
Stereotactic body radiation therapy plus induction or adjuvant chemotherapy for early stage but medically inoperable pancreatic cancer: A propensity score-matched analysis of a prospectively collected database.
Cancer Manag Res;
10: 1295-1304, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29872342